CN101301274A - Compound mequindox soluble powder for animals and preparation thereof - Google Patents
Compound mequindox soluble powder for animals and preparation thereof Download PDFInfo
- Publication number
- CN101301274A CN101301274A CNA2008100526971A CN200810052697A CN101301274A CN 101301274 A CN101301274 A CN 101301274A CN A2008100526971 A CNA2008100526971 A CN A2008100526971A CN 200810052697 A CN200810052697 A CN 200810052697A CN 101301274 A CN101301274 A CN 101301274A
- Authority
- CN
- China
- Prior art keywords
- mequindox
- soluble powder
- compound
- colistin sulfate
- sodium salicylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a compound mequindox soluble powder for animals and a preparation method thereof, which aims to provide the compound mequindox soluble powder for the animals and the preparation method, wherein, the compound mequindox soluble powder for the animals can treat the complex infection of shigella shigae and colon bacillus of pigs, is quick to take effect, can solve the treatment failure phenomenon caused by feeding and drinking conditions of the pigs during the illness, and improve the rate of liveweight growth; and the preparation method has a simple process and is easy to realize. The powder comprises the compositions in percentage by weight: 2 to 10 percent of mequindox, 0.5 to 5 percent of colistin sulfate, 6 to 30 percent of sodium salicylate, and the balance being oral glucose. The soluble powder is a compound preparation formed by a double antimicrobial drug combined with a suspending agent, has quick effect on the complex infection of the shigella shigae and the colon bacillus of the pigs due to the fact that the mequindox and the colistin sulfate are jointly used, is effective and highly efficient, can solve the treatment failure phenomenon caused by feeding and drinking problems during the illness, accelerate the recovery of the pigs, and increase the weight of the pigs.
Description
Technical field
The present invention relates to a kind of compound mequindox soluble powder for animals and preparation method thereof.
Background technology
Swine dysentery and escherichia coli mixed infection are a kind of diseases that pig often sends out in recent years, the pig digestive system is mainly encroached in swine dysentery and escherichia coli mixed infection, cause serious diarrhoea, and owing to be mixed infection, increased the mortality rate of pig greatly, and the diagnosis of disease caused very big trouble, and bring very big puzzlement for veterinary and raiser, lose for some raiser greatly.
At present, because Mequindox can specific aim be killed the dysentery that the swine dysentery bacillus causes, escherichia coli are also had certain effect, because a large amount of the use and life-time service, drug-resistance of bacteria is very high, the normal phenomenon that the treatment failure occurs.Colistin sulfate is a kind of to the effective medicine of escherichia coli, also because with the same a large amount of uses of Mequindox, cause drug resistance general, therapeutic effect reduces, simultaneously, because the dysentery bacterium in recent years and the ratio of colibacillary MOI increase, and make these two kinds of medicines of independent usefulness not reach satisfactory therapeutic effects.And both are when share, because the Mequindox powder can not be dissolved in water, the colistin sulfate soluble powder is dissolved in water, because these two kinds of medicines can not be all water-soluble, and pig suffers from dysentery and colibacillosis and makes and cause diarrhoea, generally do not like foodstuff and like drinking-water, this feed intake problem that causes because of disease when causing treatment does not reach therapeutic effect.And the raiser uses inconvenience, and it is too high and cause the phenomenon of drug waste to occur certain pharmaceutical quantities deficiency or dosage easily, and the user uses uneconomical.Simultaneously,, be difficult for to judge disease, can not suit the remedy to the case, bring difficulty, sometimes even incur loss through delay golden hour to treatment of diseases for the raiser.
Summary of the invention
The present invention is in order to overcome weak point of the prior art, provide a kind of and can treat swine dysentery and escherichia coli MOI, therapeutic effect is good, and reduces the bacterial drug resistance problem, easy to use, can obviously improve the compound mequindox soluble powder for animals of rate of body weight gain.
It is simple that another object of the present invention provides a kind of technology, easily the preparation method of the above-mentioned compound mequindox soluble powder for animals of realizing.
The present invention is achieved through the following technical solutions:
A kind of compound mequindox soluble powder for animals is characterized in that, is made by following component by weight percentage: Mequindox is 2～10%, and colistin sulfate is 0.5～5%, and sodium salicylate is 6～30%, and surplus is an oral glucose.
Wherein the preferable content of each component is: Mequindox is 3～8%, and colistin sulfate is 1～4%, and sodium salicylate is 9～24%, and surplus is an oral glucose.The optimum content of each component is: Mequindox is 5%, and colistin sulfate is 2%, and sodium salicylate is 15%, and surplus is an oral glucose.
A kind of preparation method of compound mequindox soluble powder for animals is characterized in that, comprises the steps:
(1) Mequindox, colistin sulfate, sodium salicylate and oral glucose are sieved respectively, standby;
(2) good Mequindox, colistin sulfate and sodium salicylate fully mixes in V word mixer to take by weighing sieve;
(3) will sieve good oral glucose again joins in the mixture of above-mentioned Mequindox, colistin sulfate and sodium salicylate, in common batch mixer, fully mix, discharging, sieve and obtain compound mequindox soluble powder of the present invention, make by following component by weight percentage in the compound mequindox soluble powder wherein of the present invention: Mequindox 5～20%, colistin sulfate 0.5～5%, sodium salicylate are 6～30%, and surplus is an oral glucose.
Wherein preferable consisting of: Mequindox 8～15%, colistin sulfate 1～4%, sodium salicylate are 9～24%, surplus is an oral glucose.
Best group becomes: Mequindox 5%, and colistin sulfate 2%, sodium salicylate 15%, surplus is an oral glucose.
The present invention has following technique effect:
The present invention is for adopting two kinds of compound preparations that antimicrobial drug share, Mequindox and colistin sulfate unite use, by to the rational proportion of Mequindox and colistin sulfate consumption and the cooperation hydrotropy of cosolvent sodium salicylate, has double effects, can kill swine dysentery bacillus and escherichia coli, and reduce the treatment that its drug resistance causes and lost efficacy, this product can be dissolved in water fully simultaneously, not liking of can overcoming that swine dysentery bacillus and coli-infection bring searched for food and liked the clinical symptoms of drinking-water, and treatment is accelerated, improve rate of body weight gain, and can avoid drug residue to exceed standard.And the user treats the disease use under the situation that can not distinguish swine dysentery bacillus and escherichia coli MOI more convenient, because drug dose is little, instant effect has reduced use cost.
The preparation method technology of compound mequindox soluble powder for animals of the present invention is simple, realizes easily.
The specific embodiment
Below in conjunction with specific embodiment to the detailed description of the invention.
Embodiment 1
(1) Mequindox, colistin sulfate, sodium salicylate, oral glucose are crossed the 24# sieve respectively, standby.
(2) good Mequindox 2kg fully mixed 30 minutes in V word mixer with colistin sulfate 5kg, sodium salicylate 6kg to take by weighing sieve.
(3) will sieve in the mixture that good oral glucose 87kg joins above-mentioned Mequindox and colistin sulfate, sodium salicylate again, and fully mix 30 minutes in common batch mixer, discharging is crossed the 24# sieve and is obtained compound mequindox soluble powder of the present invention.
Embodiment 2
(1) Mequindox, colistin sulfate, sodium salicylate and oral glucose are crossed the 24# sieve respectively, standby.
(2) good Mequindox 10kg fully mixed 30 minutes in V word mixer with colistin sulfate 0.5kg, sodium salicylate 30kg to take by weighing sieve.
(3) will sieve in the mixture that good oral glucose powder 59.5kg joins above-mentioned Mequindox and colistin sulfate, sodium salicylate again, and fully mix 30 minutes in common batch mixer, discharging is crossed the 24# sieve and is obtained compound mequindox soluble powder of the present invention.
Embodiment 3
(1) Mequindox, colistin sulfate, sodium salicylate and oral glucose are crossed the 24# sieve respectively, standby.
(2) good Mequindox 3kg fully mixed 30 minutes in V word mixer with colistin sulfate 4kg, sodium salicylate 9kg to take by weighing sieve.
(3) will sieve in the mixture that good oral glucose powder 84kg joins above-mentioned Mequindox and colistin sulfate, sodium salicylate again, and fully mix 30 minutes in common batch mixer, discharging is crossed the 24# sieve and is obtained compound mequindox soluble powder of the present invention.
Embodiment 4
(1) Mequindox, colistin sulfate, sodium salicylate and oral glucose are crossed the 24# sieve respectively, standby.
(2) good Mequindox 8kg fully mixed 30 minutes in V word mixer with colistin sulfate 1kg, sodium salicylate 24kg to take by weighing sieve.
(3) will sieve in the mixture that good oral glucose powder 67kg joins above-mentioned Mequindox and colistin sulfate, sodium salicylate again, and fully mix 30 minutes in common batch mixer, discharging is crossed the 24# sieve and is obtained compound mequindox soluble powder of the present invention.
Embodiment 5
(1) Mequindox, colistin sulfate, sodium salicylate and oral glucose are crossed the 24# sieve respectively, standby.
(2) good Mequindox 6kg fully mixed 30 minutes in V word mixer with colistin sulfate 1.5kg, sodium salicylate 24kg to take by weighing sieve.
(3) will sieve in the mixture that good oral glucose powder 68.5kg joins above-mentioned Mequindox and colistin sulfate, sodium salicylate again, and fully mix 30 minutes in common batch mixer, discharging is crossed the 24# sieve and is obtained compound mequindox soluble powder of the present invention.。
Embodiment 6
(1) Mequindox, colistin sulfate, sodium salicylate and oral glucose are crossed the 24# sieve respectively, standby.
(2) take by weighing sieve good Mequindox 5kg and colistin sulfate 2kg, sodium salicylate 15kg, in V word mixer, fully mixed 30 minutes.
(3) will sieve good oral glucose 78kg again and join in the mixture of above-mentioned Mequindox and colistin sulfate, and fully mix 30 minutes in common batch mixer, discharging is crossed the 24# sieve and is obtained compound mequindox soluble powder of the present invention.
Clinical trial:
1. laboratory animal:
Only 100 of the ill one-tenth of picked at random pigs, body weight is at 30～60kg.
2. experiment medicine
The compound mequindox soluble powder our unit development of the embodiment of the invention 6 preparations;
5% Mequindox powder our unit prepared in laboratory;
2% colistin sulfate powder our unit prepared in laboratory.
3. experimental technique:
Suffer from pig with 100 and be divided into four groups at random by body weight, 25 every group.
The A group does not give Drug therapy for the blank group.
The B group is treated usage with 10% Mequindox powder: spice is for oral administration, every 1kg body weight 0.2g, 2 times on the one, logotype 4 days.
The C group is treated usage with 2% colistin sulfate: drinking-water is for oral administration, every 1kg body weight 0.2g, 2 times on the one, logotype 4 days.
The D group is treated usage with the compound mequindox soluble powder of the embodiment of the invention 6 preparations: drinking-water is for oral administration, every 1kg body weight 0.2g, 2 times on the one, logotype 2 days.
After the treatment beginning, every day, record trouble poultry health situation of change and dead animal distributed, and treat and add up therapeutic effect after 10 days, wherein:
Invalid: as after referring to 10 days, to suffer from the poultry symptom and do not have obvious change, still keep the preceding symptom of treatment.
Effectively: after referring to 10 days, suffer from the poultry symptom and change, the effect before symptom is better than treating.
Cure: after referring to 10 days, transference cure is suffered from poultry and is got well.Its numeral is included in the significant digits.
Symptom is arranged during end: after referring to 10 days, suffer from poultry and still have certain symptom, its symptom performance is better than before the treatment or does not have change, suffers from poultry and does not cure.Its numeral has been included in the numeral of invalid number and effective number.
The relative weight gain rate: refer to use behind the medicine rate of body weight gain with respect to matched group.
Result of the test is as shown in table 1.
4. conclusion:
Analyze by statistics from the result of the test of table 1, compound mequindox soluble powder treatment group, Mequindox treated powder group and colistin sulfate powder and matched group difference is (P＜0.01) extremely significantly.Curative effect of the present invention is better than existing two kinds of medicines.
Table 1
| Numbering | Group | Invalid number | Effective number | Cure a number | Symptom pig's head number is arranged during end | A dead number | The relative weight gain rate % |
| A | Matched group | 25 | 0 | 0 | 8 | 17 | 0 |
| B | 5% Mequindox powder | 8 | 17 | 15 | 5 | 5 | 61.2 |
| C | 2% colistin sulfate powder | 12 | 13 | 8 | 10 | 7 | 30.5 |
| D | Compound mequindox soluble powder | 2 | 23 | 21 | 3 | 1 | 90.0 |
Claims (6)
1, a kind of compound mequindox soluble powder for animals is characterized in that, is made by following component by weight percentage: Mequindox is 2～10%, and colistin sulfate is 0.5～5%, and sodium salicylate is 6～30%, and surplus is an oral glucose.
2, compound mequindox soluble powder for animals according to claim 1 is characterized in that, is made by following component by weight percentage: Mequindox is 3～8%, and colistin sulfate is 1～4%, and sodium salicylate is 9～24%, and surplus is an oral glucose.
3, compound mequindox soluble powder for animals according to claim 1 is characterized in that, is made by following component by weight percentage: Mequindox is 5%, and colistin sulfate is 2%, and sodium salicylate is 15%, and surplus is an oral glucose.
4, a kind of preparation method of compound mequindox soluble powder for animals is characterized in that, comprises the steps:
(1) Mequindox, colistin sulfate, sodium salicylate, oral glucose are sieved respectively, standby;
(2) good Mequindox fully mixes in V word mixer with colistin sulfate, sodium salicylate to take by weighing sieve;
(3) will sieve again in the mixture that good oral glucose joins above-mentioned Mequindox and colistin sulfate, sodium salicylate, in common batch mixer, fully mix, discharging, sieve and obtain compound mequindox soluble powder of the present invention, made by following component by weight percentage in the compound mequindox soluble powder wherein of the present invention: Mequindox is 2～10%, colistin sulfate is 0.5～5%, and sodium salicylate is 6～30%, and surplus is an oral glucose.
5, the preparation method of compound mequindox soluble powder for animals according to claim 4 is characterized in that, described Mequindox is 3～8%, and colistin sulfate is 1～4%, and sodium salicylate is 9～24%, and surplus is an oral glucose.
6, the preparation method of compound mequindox soluble powder according to claim 4 is characterized in that, described Mequindox is 5%, and colistin sulfate is 2%, and sodium salicylate is 15%, and surplus is an oral glucose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100526971A CN101301274B (en) | 2008-04-11 | 2008-04-11 | Compound mequindox soluble powder for animals and preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100526971A CN101301274B (en) | 2008-04-11 | 2008-04-11 | Compound mequindox soluble powder for animals and preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101301274A true CN101301274A (en) | 2008-11-12 |
| CN101301274B CN101301274B (en) | 2010-09-01 |
Family
ID=40111494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100526971A Expired - Fee Related CN101301274B (en) | 2008-04-11 | 2008-04-11 | Compound mequindox soluble powder for animals and preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101301274B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108853024A (en) * | 2018-07-27 | 2018-11-23 | 洛阳瑞华动物保健品有限公司 | A kind of colistin sulphate soluble powder and preparation method thereof |
| CN111214436A (en) * | 2020-03-18 | 2020-06-02 | 潍坊富邦药业有限公司 | Method for preparing mequindox injection by inclusion process |
-
2008
- 2008-04-11 CN CN2008100526971A patent/CN101301274B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108853024A (en) * | 2018-07-27 | 2018-11-23 | 洛阳瑞华动物保健品有限公司 | A kind of colistin sulphate soluble powder and preparation method thereof |
| CN111214436A (en) * | 2020-03-18 | 2020-06-02 | 潍坊富邦药业有限公司 | Method for preparing mequindox injection by inclusion process |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101301274B (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2224918T3 (en) | The use of EDTA and its salts for the prevention and treatment of bacterial intestinal diseases of pigs | |
| CN103494832B (en) | A kind of compound ivermectin albendazole transdermal agent for livestock and using method thereof | |
| CN104800167A (en) | Florfenicol soluble powder and preparation method thereof | |
| CN101450067A (en) | Premixing agent for treating and preventing livestock and poultry respiratory disease | |
| CN101301274B (en) | Compound mequindox soluble powder for animals and preparation thereof | |
| CN101590019A (en) | Soluble compound doxycycline hyclate powder for animals and preparation method thereof | |
| CN101628109A (en) | Compound neomycin sulphate solution and preparation method thereof | |
| CN100548301C (en) | Be used for the treatment of injection of swine dysentery and preparation method thereof | |
| CN106620668A (en) | Compound tilmicosin solid dispersing agent and preparation method thereof | |
| CN101450061A (en) | Soluble powder for treating poultry bacterial infection | |
| CN101670094A (en) | Compound gentamycin sulfate soluble powder and preparation method thereof | |
| CN102274318A (en) | Pure traditional Chinese medicine composition for treating poultry coccidiosis and preparation method thereof | |
| CN101966201A (en) | Compound norfloxacin nicotinic soluble powder and preparation method thereof | |
| CN101829129B (en) | Veterinary compound gentamycin sulfate injection and preparation method thereof | |
| CN101642460A (en) | Compound solution of diclazuril for curing avian coccidium infection and preparation method thereof | |
| CN101468025A (en) | Soluble powder for preventing and treating colibacillosis of fowl | |
| CN101297813A (en) | Compound niacin norfloxacin injection for animals and preparation thereof | |
| CN100515425C (en) | Medicine composition for preventing and treating farm animal's respiratory tract and digestive tract diseases | |
| CN101966200A (en) | Composition for treating poultry digestive tract bacterial infection and preparation method thereof | |
| CN101653417A (en) | Compound colistin sulfate soluble powder for treating lamb dysentery and preparation method thereof | |
| CN101433543A (en) | Compound mequindox injection | |
| CN101653486A (en) | Compound Bailongsan for treating diarrhoea of nursery pig and preparation method thereof | |
| CN101297795B (en) | Compound florfenicol powder for animals and preparation thereof | |
| CN101422477A (en) | Compound apramycin sulfate injection | |
| CN104645311A (en) | Drinking agent for treating intestinal infection of livestock and poultry and preparation method of drinking agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100901 Termination date: 20130411 |